Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the long term effects of two types of hormonal
treatment for advanced prostate cancer (LHRH agonists and the antiandrogen bicalutamide)on
the bone mineral density of patients.